BioSpace News Archive

Pharm Country

Published Research Shows Initial Results from SARS-CoV-2 Surveillance Studies Support U.S. Public Health Initiatives

Infinity BiologiX LLC d/b/a Sampled, a next generation SMART Lab, and co-authors report results from the CDC SARS-CoV-2 variant surveillance program.

April 27, 2022
·
3 min read
Active Pharmaceutical Ingredients (API) Market Size to Reach US$ 328 Bn by 2030

The global active pharmaceutical ingredients market size is expected to reach around US$ 328 billion by 2030. The global active pharmaceutical ingredients market size was valued at US$ 169 bn in 2020 and is anticipated to grow at a CAGR of 6.1% from 2021 to 2030.

April 27, 2022
·
8 min read
Dental Services Market Size, Growth, Trends 2022-2030

The Dental Services Market size was estimated at US$ 310.7 billion in 2020 and is anticipated to grow at a CAGR of 6.10% during forecast period 2021 to 2030.

April 27, 2022
·
5 min read
Business

Calliditas Therapeutics’ 2021 Annual Report Published

Calliditas Therapeutics AB announces that the Annual Report for 2021 now is available at the company’s website.

April 27, 2022
·
3 min read
Business

Highland Therapeutics Announces Appointment of Stephanie C. Read as President/CEO, Changes to Board of Directors

Highland Therapeutics Inc. today announced the appointment of Stephanie C. Read as President/Chief Executive Officer, the appointment of Scott Myers as Chair of the Board and the additions of Kevin Bain and Ildiko Mehes as independent members of the Board of Directors.

April 27, 2022
·
12 min read
Genetown

Praxis Precision Medicines Showcases Largest Targeted Epilepsy Portfolio in Industry at 2022 Epilepsy DayLive event in New York City and webcast to start at 8:30 a.m. ET

Praxis Precision Medicines, Inc. will host its 2022 Epilepsy Day live in New York City and via webcast from 8:30 to 11:30 a.m. ET.

April 27, 2022
·
4 min read
Genetown

T2 Biosystems Announces Submission for FDA Breakthrough Device Designation for T2Biothreat Panel

T2 Biosystems, Inc. announced today that it has submitted an application with the U.S. Food and Drug Administration (FDA) for Breakthrough Device Designation for the Company’s T2Biothreat™ Panel.

April 27, 2022
·
5 min read
Business

Allogene Therapeutics to Report First Quarter 2022 Financial Results on May 4, 2022

Allogene Therapeutics, Inc. today announced that it will report first quarter 2022 financial results on Wednesday, May 4, 2022 after the close of the market.

April 27, 2022
·
2 min read
BioCapital

Emmes and Casimir Announce Research About a Novel, Home-Based Assessment for Duchenne Muscular Dystrophy

Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that Casimir’s research on the development of the Duchenne Video Assessment (DVA) scorecards was published in PLOS ONE.

April 27, 2022
·
3 min read
Cloud DX Announces Closing of Private Placement

Additional details are available in the Loan Agreement which is available under the Corporation’s SEDAR profile at www.sedar.com.

April 27, 2022
·
5 min read